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Abstract
Mycobacterium tuberculosis employs various virulence strategies to subvert host immune responses in order to persist and
cause disease. Interaction of M. tuberculosis with mannose receptor on macrophages via surface-exposed lipoarabino-
mannan (LAM) is believed to be critical for cell entry, inhibition of phagosome-lysosome fusion, and intracellular survival,
but in vivo evidence is lacking. LprG, a cell envelope lipoprotein that is essential for virulence of M. tuberculosis, has been
shown to bind to the acyl groups of lipoglycans but the role of LprG in LAM biosynthesis and localization remains unknown.
Using an M. tuberculosis lprG mutant, we show that LprG is essential for normal surface expression of LAM and virulence of
M. tuberculosis attributed to LAM. The lprG mutant had a normal quantity of LAM in the cell envelope, but its surface was
altered and showed reduced expression of surface-exposed LAM. Functionally, the lprG mutant was defective for
macrophage entry and inhibition of phagosome-lysosome fusion, was attenuated in macrophages, and was killed in the
mouse lung with the onset of adaptive immunity. This study identifies the role of LprG in surface-exposed LAM expression
and provides in vivo evidence for the essential role surface LAM plays in M. tuberculosis virulence. Findings have
translational implications for therapy and vaccine development.
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Introduction
Mycobacterium tuberculosis is a human pathogen that has
infected one-third of world’s population and causes 8 million new
cases and over one million deaths each year [1]. In the absence of
a protective vaccine and the global prevalence of drug resistant
strains, a greater understanding of virulence mechanisms is needed
to facilitate development of anti-tuberculosis drugs with novel
mechanisms of action. M. tuberculosis utilizes multiple defensive
and offensive strategies to subvert the host immune responses in
order to persist and cause disease [2]. Many of the virulence
determinants of M. tuberculosis are constituents of the cell
envelope [3]. The mycobacterial cell envelope is an impermeable
barrier composed of an inner plasma membrane; a cell wall core;
an outer mycomembrane; and a surface capsule composed of
polysaccharides, lipids, and proteins [4–6]. The constituents of the
capsule can be concealed within the ,35 nm capsular layer or
they can be exposed on the surface with the ability to interact with
the host [6]. Mannose-capped lipoarabinomannan (LAM), an
abundant surface-exposed lipoglycan anchored to the inner
and outer membranes via a mannosyl phosphate inositol [7],
is considered one of the key virulence determinants of
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M. tuberculosis [6,8–11]. Upon contact with macrophages,
surface-exposed LAM binds to macrophage mannose receptor
(MMR) and facilitates entry, inhibition of Phagosome-Lysosome
(P-L) fusion, and modulation of immune responses leading to
intracellular survival and persistence [12–16]. However, our
understanding of LAM function is derived from in vitro studies
using purified LAM. Confirmation of these findings in vivo using
M. tuberculosismutants has not been possible due to the essentiality
of genes involved in lipoglycan biosynthetic pathway [8,9].
Bacterial lipoproteins are membrane-anchored cell envelope
proteins with a broad range of functions including substrate-
binding and transport [17]. Using a Toll-like receptor 2 assay to
detect agonist activity from mycobacterial lysates, Drage and
colleagues unexpectedly found that M. tuberculosis lipoprotein
LprG binds to LAM and other lipoglycans [18]. Using X-ray
crystallography, they showed that LprG forms a hydrophobic
pocket that accommodates the alkyl chains of tri-acylated
lipoglycans and mutation of the hydrophobic pocket (LprG
V91W) abrogates association of LprG with lipoglycans. The
genome of M. tuberculosis encodes lprG (Rv1411c) in an operon
that also encodes Rv1410c, a major facilitator superfamily small
molecule transporter P55 [19]. Both LprG and P55 are required
for the efflux activity of P55 using exogenous substrates suggesting
that both proteins mediate the same endogenous function [20,21].
Although lprG is essential for survival of M. tuberculosis in mice
[22,23], the function of LprG in LAM biosynthesis and
localization remains unknown.
In this study we used a M. tuberculosis lprG deletion mutant to
investigate the role of LprG in LAM biosynthesis and pathogen-
esis. We show that (i) LprG is essential for normal expression of
surface LAM and (ii) the virulence properties of M. tuberculosis
attributed to LAM are defective in the lprG mutant.
Results
Fitness of lprG mutant is unaltered in broth culture
To investigate the function of LprG in M. tuberculosis, we
constructed a deletion mutant of lprG (DlprG) in H37Rv and
complemented it with lprG-Rv1410c (::lprG) (Figure S1). Deletion
of lprG had no effect on the growth of M. tuberculosis in
Middlebrook 7H9 broth (Figure S2A). On Middlebrook 7H9 agar,
the diameter of DlprG colonies was on average reduced by 47%
compared to H37Rv and ::lprG (Figure S2B). To investigate the
length and diameter of DlprG bacilli, scanning electron micros-
copy (SEM) and atomic force microscopy (AFM) were performed
on the bacteria and their imprints on polydimethylsiloxane
(PDMS) polymer surface, respectively. SEM and AFM did not
show any dimension differences between H37Rv and DlprG
(Figure S3). Both strains measured ,2.4 mm long and 0.27 mm
wide by SEM and had an imprinted depth of 0.26 mm.
lprG mutant has normal LAM content
To investigate the role of LprG in LAM biosynthesis and
transport, the cellular, capsular, and secreted lipoglycan and lipid
composition of DlprG were analyzed in non-shaking and shaking
cultures without detergent. As shown in Figure 1A and B, using
SDS/PAGE stained with periodic acid/Schiff reagent and thin-
layer chromatography, comparable amounts of LAM and its
precursors- phosphatidylinositol mannosides and lipomannan-
were recovered from H37Rv and DlprG cells. The phosphatidy-
linositol mannosides composition as determined by MALDI-TOF
MS was identical (unpublished data). As a complementary
approach, we assessed the cellular LAM content using SDS/
PAGE immunoblot. The immunoblot showed no difference
between H37Rv and DlprG (Figure 1C). Consistent with these
observations, the mannose, inositol, and arabinose composition of
whole delipidated DlprG cells was not significantly different from
that of the H37Rv (Table 1). Likewise, both strains displayed
similar glycan contents in their culture filtrate and capsular
materials indicating that their capsular lipoglycan compositions
were not altered [24]. Biochemical methods also did not reveal any
significant quantitative or qualitative differences in the lipid
composition between H37Rv and DlprG, apart from a decrease in
trehalose dimycolate in the lprG mutant cells growing in shaking
broth but not on agar (Figure 1B and Figure S4). We also assessed
the major capsular polysaccharide a-glucan by a spot immunoblot
assay and did not find a difference between H37Rv and DlprG
(Figure 1D). Altogether, these findings consistently indicate that
LprG does not play a role in the biogenesis of LAM.
lprG mutant has reduced expression of surface-exposed
LAM
To investigate the surface property of DlprG and determine the
role of LprG in expression of LAM on the surface [10], we
employed cell-imprinting technology [25,26]. As illustrated in
Figure 2A, cell-imprinting cures PDMS polymer solution around
bacteria of interest. During contact, functional groups in the
polymer solution arrange around the template cells. After
removing the template cells, the cavities left on the imprinting
polymer surface serve as receptors for preferential capture of
template cells based on the chemical property of their surface.
When cells of DlprG were passed through a microfluidic device
containing imprints of H37Rv, DlprG, and ::lprG, the mutant cells
were selectively captured on imprints of DlprG compared to
imprints of H37Rv and ::lprG (Figure 2B and C). On average
58.364.0 DlprG cells were captured per field on imprint of DlprG
compared to 34.063.6 (P,0.005) and 35.763.5 (P,0.005) DlprG
cells captured on imprints of H37Rv and ::lprG, respectively
(Table S1). In contrast, the cells of H37Rv and ::lprG were
preferentially captured on imprints of H37Rv and ::lprG
compared to imprints of DlprG (Figure 2B and C). On average
44.764.0 (P,0.01) and 43.764.2 (P,0.05) H37Rv cells and
Author Summary
Mycobacterium tuberculosis is among the leading infectious
causes of human death. A better understanding of its
virulence mechanisms is needed to facilitate development
of novel therapeutics and a preventative vaccine. Lipoar-
abinomannan (LAM), an abundant surface-exposed lipo-
glycan, is believed to be a critical virulence determinant for
intracellular survival and latency of M. tuberculosis. In vitro
experiments with purified LAM have led to a model in
which surface-exposed LAM binds to macrophage man-
nose receptor and facilitates bacterium entry, inhibition of
phagosome-lysosome fusion, and modulation of innate
immune responses. However, confirmation of these
findings in vivo has not been possible due to the
essentiality of genes involved in the LAM biosynthetic
pathway. It was recently shown that LprG, a cell envelope
lipoprotein, binds to the acyl groups of lipoglycan, but the
role of LprG in LAM biosynthesis and localization remains
unknown. Here, using an M. tuberculosis lprG mutant and a
novel cell-imprinting assay, we show that LprG is essential
for normal surface expression of LAM and virulence of M.
tuberculosis attributed to LAM. Our study provides new
insights into the mechanism of surface expression of LAM
and confirms the essential role surface LAM serves in
pathogenesis of M. tuberculosis.
LprG-Mediated Surface Expression of LAM in M. tuberculosis
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42.064.0 (P,0.05) and 43.363.5 (P,0.01) ::lprG cells were
captured on imprints of H37Rv and ::lprG, respectively, compared
to 29.363.5 H37Rv and 28.764.0 ::lprG cells captured on
imprints of DlprG (Table S1). These results confirm that DlprG has
an altered surface compared to H37Rv and ::lprG. To determine
whether the cell surface alteration in DlprG is a common feature of
other cell envelope mutants, we measured the capture of M.
tuberculosis DlspA [27] and DwhiB3 [28] on imprints of H37Rv,
DlprG, and ::lprG. As shown in Figure 2C, both DlspA and
DwhiB3 cells were captured preferentially on imprints of H37Rv
and ::lprG compared to imprints of DlprG. On average 39.363.5,
30.363.5 (P,0.05), and 39.763.1 DlspA cells and 38.063.6,
31.763.5, and 38.763.5 DwhiB3 cells were captured on imprints
of H37Rv, DlprG, and ::lprG, respectively (Table S1). These
findings indicate the cell surface alteration in DlprG is not a
common feature of cell envelope mutants.
To determine if the altered surface property of DlprG is caused
by differential expression of surface LAM, bacteria were pretreat-
ed with anti-LAM antibody and then captured on imprints.
Blocking surface LAM with two different anti-LAM antibodies, a-
LAM and CS-35, abolished selective capture of H37Rv and ::lprG
on imprints of H37Rv and ::lprG compared to imprint of DlprG
(Figure 2D and unpublished data). On average 30.063.6, 27.363.5,
and 27.763.1 H37Rv cells and 28.363.5, 25.363.5, and 26.363.5
::lprG cells were captured on imprints of H37Rv, DlprG, and ::lprG,
respectively, after blocking with a-LAM (Table S2). Pretreatment of
DlprG cells with anti-LAM had no effect on selective capture of DlprG
cells on imprint of DlprG compared to imprints of H37Rv and ::lprG.
On average 32.364.0, 54.764.5 (P,0.005), and 33.763.5DlprG cells
were captured on imprints of H37Rv, DlprG, and ::lprG, respectively
(Table S2). To show that the blocking effect of anti-LAM was specific,
bacteria were pretreated with an antibody to Ag85c complex, a cell
Figure 1. The lprG mutant has normal LAM content in the cell envelope. (A) SDS/PAGE analysis of phosphatidylinositol mannosides (PIMs),
lipomannan (LM) and LAM prepared from wild-type (H37Rv), lprG mutant (DlprG), and DlprG complemented with lprG-Rv1410c (::lprG). LM and LAM
extracted from equal amounts of bacterial cells were separated on a 10–20% Tricine gel and visualized by periodic acid/Schiff reagent staining. (B)
Thin-layer chromatograms of total lipids extracted from H37Rv and DlprG. The same amounts of total lipids extract from bacilli grown in GAS medium
were loaded for each strain. Thin-layer chromatogram plates were run in the solvent system CHCl3/CH3OH/H2O (65:25:4, by vol.) and revealed with a-
naphthol. SL, sulfolipid; TMM, trehalose monomycolates; DAT, diacyltrehaloses; PE, phosphatidylethanolamine; CL, cardiolipin; PIM2, phosphatidy-
linositol dimannoside; PI, phosphatidylinositol; PIM6, phosphatidylinositol hexamannosides. (C) SDS/PAGE immunoblot for LAM analysis in H37Rv and
DlprG cellular extracts. Extracts normalized to protein concentration were separated on a 15% SDS/PAGE gel and transferred to PVDF membrane. The
blot was blocked, and then stained with anti-LAM pAb (a-LAM) followed by goat anti-rabbit IgG-HRP secondary antibody. The blot was washed and
imaged after adding 30% 3,39-diaminobenzidine tetrahydrochloride solution plus 0.0005% H2O2. LAM Std, purified H37Rv LAM standard. (D) Spot
immunoblot for analysis of capsular a-glucan. Capsular content extracted from equal numbers of bacteria were spotted on PVDF membrane and
stained with goat anti-phosphatidylinositol-glycans pAb followed by donkey anti-goat IgG-HRP secondary antibody. The membrane was developed
and imaged as described in C. Dilutions of extract spotted on membrane are shown. Data is representative of two independent experiments.
doi:10.1371/journal.ppat.1004376.g001
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wall antigen not expressed on the surface. Treatment of bacteria with
anti-Ag85c complex had no effect on selective capture of H37Rv or
::lprG on H37Rv and ::lprG imprints (Figure 2E and Table S3).
Similar results were obtained with an isotype control for CS-35 (Figure
S5 and Table S4).
To generate additional evidence for altered expression of
surface LAM on DlprG, we used indirect fluorescent antibody
staining to measure the expression of surface-exposed LAM. Surface
staining with anti-LAM, but not secondary antibody alone, showed
a lower percent of DlprG cells staining positive with a-LAM and
CS-35 compared to H37Rv and ::lprG (Figure 3). On average
45.360.18% and 41.364.2% of DlprG cells stained positive with a-
LAM and CS-35, respectively, compared to 81.463.6% (P,0.001)
and 86.0614.3% (P,0.01) of H37Rv cells and 84.166.0% (P,
0.01) and 73.1617.8% (P,0.05) of ::lprG cells, respectively. A
higher fraction of positively staining DlprG cells stained dim
compared to H37Rv and ::lprG. On average 92.0% and 100% of
DlprG stained dim with a-LAM and CS-35, respectively, compared
to 48.9% and 40.7% of H37Rv and 66.0% and 36.0% of ::lprG,
respectively. Altogether, a notable difference between H37Rv and
DlprG was the abundance of surface-exposed LAM, indicating
LprG is important for normal surface expression of LAM.
lprG mutant is attenuated for macrophage entry and
inhibition of Phagosome-Lysosome fusion
Interaction of M. tuberculosis with the host through binding of
surface LAM to MMR on macrophages facilitates cell entry and
inhibition of P-L fusion [14–16]. Thus, we measured the efficiency
of DlprG for cell entry and inhibition of P-L fusion. To measure
cell entry, we infected mouse bone marrow-derived macrophages
(BMMW) and determined the numbers of intracellular viable
bacteria 4 h after infection. As shown in Figure 4A, infection with
similar numbers of organisms of each strain resulted in recovery of
a significantly lower number of the DlprG compared to H37Rv
and ::lprG. On average 1,1146277 DlprG cells were recovered per
well compared to 3,3636992 (P,0.05) H37Rv and 2,2566431
(P,0.05) ::lprG cells. To show that the superior entry of H37Rv
and ::lprG was dependent on their interaction with MMR, we
used 4 mg/ml mannan and 0.5 mg/ml anti-MMR to block MMR
on RAW 264.7 macrophages prior to infection. Without blocking,
18.268.4% of RAW cells were infected with DlprG compared to
59.765.4% (P,0.05) with H37Rv and 51.164.3% (P,0.05) with
::lprG (Figure 4B). Blocking the MMR with mannan (Figure 4C)
and anti-MMR (Figure 4D) abolished differences in the percent-
age of RAW cells infected with H37Rv and DlprG. On average
5.761.0% and 3.861.4% of cells were infected with H37Rv and
6.562.2% and 6.361.5% of cells were infected with DlprG after
treatment with mannan and anti- MMR, respectively.
To investigate P-L fusion, we measured the percentage of
intracellular bacteria in RAW cells that co-localized with
lysosomes stained with LysoTracker-Red. As shown in confocal
images (Figure 5A) and in a graph (Figure 5B), co-localization of
DlprG with lysosomes was increased compared to H37Rv and
::lprG. On average 71.363.3% of DlprG co-localized with
lysosomes compared to 48.668.7% (P,0.05) of H37Rv and
44.765.8% (P,0.01) of ::lprG. Blocking the MMR with mannan
(Figure 5C) and anti-MMR (Figure 5D) abolished co-localization
differences between H37Rv and DlprG. On average 86.662.2%
and 89.665.8% of H37Rv and 92.767.3% and 81.3612.5% of
DlprG co-localized with lysosomes in cells treated with mannan
and anti-MMR, respectively. These findings confirm that LprG is
essential for optimal macrophage entry and inhibition of P-L fusion.
lprG mutant burden declines in the mouse lung with the
onset of adaptive immunity
To characterize the kinetics of DlprG replication in the mouse
lung model, we infected wild-type C57BL/6 mice with aerosolized
bacteria and assessed bacterial burden and lung pathology during
acute and chronic phases of infection. As shown in Figure 6A,
DlprG was attenuated during the acute and chronic phases of
infection. Although DlprG could replicate in the mouse lung, on
day 10 the burden of DlprG was on average 8.3 and 14.5 fold
lower than H37Rv (P,0.01) and ::lprG (P,0.01), respectively.
With the onset of adaptive immunity [29], the burden of DlprG
started to decline. On day 70, the burden of DlprG was reduced by
2,805 and 2,721 fold compared to H37Rv (P,0.005) and ::lprG
(P,0.005), respectively. Gross examination on day 70 revealed
normal sized lungs with no or small lesions in mice infected with
DlprG (Figure 6B). In contrast, mice infected with H37Rv and ::lprG
had edematous lungs with numerous large granulomatous lesions.
Attenuation of lprG mutant is not rescued in p-
47phox2/2 and iNos2/2 macrophages
To determine whether the mechanism of in vivo attenuation of
DlprG is due to hypersensitivity to reactive oxygen or nitrogen
species, we investigated the growth and survival of DlprG in BMMW
Table 1. The glycosyl composition of the delipidated cells, capsules and culture filtrates of the H37Rv and lprG mutant (DlprG)
strains.
Source Strain Ino+Ara+Man/total sugars Glc/total sugars Ino/total sugars Ara/total sugars Man/total sugars
Delipidated cells
H37Rv 0.23 0.34 0.02 0.07 0.14
DlprG 0.28 0.32 0.03 0.10 0.15
Capsule
H37Rv 0.17 0.82 0.02 0.02 0.14
DlprG 0.14 0.84 0.02 0.02 0.10
Culture filtrates
H37Rv 0.47 0.30 0.14 0.13 0.20
DlprG 0.48 0.28 0.15 0.14 0.18
Ino, myo-Inositol; Ara, arabinose; Man, mannose; Glc, glucose.
Values are expressed as molar ratios.
doi:10.1371/journal.ppat.1004376.t001
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Figure 2. Cell-imprinting reveals altered cell surface and reduced surface-exposed LAM in the lprG mutant. (A) Illustration of cell-
imprinting and cell capture. Equal number of bacteria grown in shaking broth culture with Tween-80 were fixed in paraformaldehyde, washed with
PBS, dried on a polystyrene glass slide, and then used as a template for imprinting. The template was pressed into pre-cured PDMS polymer which
was then cured at 37uC for 8 h, followed by 60uC for 1 h. The template was peeled off and the imprinted polymer film was sonicated in distilled water
for 5 min. Samples of bacteria suspended in PBS at an ODA580 of 0.01 were fluorescently labeled with propidium iodide and 25 ml was flowed at 5 ml/
min through a microfluidic device containing the imprints of wild-type (H37Rv), lprG mutant (DlprG), and DlprG complemented with lprG-Rv1410c
(::lprG). The average number of captured bacilli per eight view fields was measured using a fluorescent microscope. (B) Representative images
showing captured H37Rv, DlprG, and ::lprG on imprints of H37Rv and DlprG. (C–E) Bar graphs show the average number of captured H37Rv, DlprG,
::lprG, lspAmutant (DlspA) and whiB3mutant (DwhiB3). Samples were pretreated with PBS alone (C), with rabbit anti-LAM pAb (a-LAM) at a dilution of
1/20 (D) and with mouse anti-Ag85 complex mAb (CS-90) at a dilution of 1/10 (E). Data is representative of three independent experiments. Capture
on imprints of DlprG and ::lprG was compared to H37Rv. *P,0.05; **P,0.01; ***P,0.005.
doi:10.1371/journal.ppat.1004376.g002
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from wild-type (C57BL/6), p-47phox2/2, and iNOS2/2 mice.
Intracellular bacilli in resting and IFN-c-activated BMMW were
enumerated on day 0, 2 and 5 post-infection. The lprG mutant was
attenuated in resting and IFN-c-activated wild-type macrophages
(Figure 7A, B, E and F). Because DlprG is attenuated for cell entry,
we determined the fold-change in colony forming units (CFU)
between day 0 and 5. On average, fold-change inDlprGwas 5.2 and
1.1 in resting and IFN-c-activated macrophages, respectively,
compared to 16.5 (P,0.001) and 3.2 (P,0.01) in H37Rv and
14.3 (P= 0.07) and 3.5 (P,0.05) in ::lprG, respectively. As shown in
Figure 7, attenuation of DlprG was not reversed in p-47phox2/2
(Figure 7C and D) or iNOS2/2 (Figure 7G and H) macrophages.
On day 5, on average, 8,767 and 1,183 DlprG were recovered per
well from resting and IFN-c-activated p-47phox2/2macrophages,
respectively, compared to 9,667 and 1,683 from wild-type
macrophages, respectively. In iNOS2/2 macrophages, 138,333
and 35,000 DlprG were recovered from resting and IFN-c-activated
macrophages, respectively, compared to 108,333 and 26,667 from
wild-type macrophages, respectively.
Discussion
Here we provide evidence that LprG is essential for normal
surface expression of LAM in M. tuberculosis. We showed that the
lprG mutant has normal abundance of lipids, lipoglycans, and
glycans in the cell wall and the capsule, but it has an altered
surface with reduced expression of surface-exposed LAM. This
finding is consistent with prior studies showing the lprG mutant of
M. smegmatis is defective for colony sliding motility [21] and ofM.
bovis BCG displays increased clumping in broth [30], both of
which are properties associated with cell surface alteration. The
exact mechanism through which LprG and P55 facilitate normal
surface expression of LAM remains to be determined. The finding
that LAM does not accumulate in the cell envelope or culture
filtrate of the lprG mutant rules out the possibility that LprG plays
a role in transport or anchoring of LAM, respectively. Further-
more, normal migration of LAM on SDS/PAGE blots together
with unchanged capsular glycan content suggests LprG is not
involved in elaboration of the LAM side-chains. Drage and
colleagues showed that LprG associates with LAM through a
hydrophobic pocket that accommodates the alkyl chains of tri-
acylated lipoglycans [18]. Thus, we speculate LprG serves to
orient LAM on the cell surface in order to maximize exposure of
its mannose cap residues. This would be consistent with the
paradigm that M. tuberculosis depends on surface-exposed LAM
to bind to MMR in order to facilitate cell entry and inhibition of
P-L fusion [14–16]. Misorientation of surface LAM in the lprG
mutant would also explain reduced but not null expression of
Figure 3. Surface staining reveals reduced LAM on the lprG mutant cells. Indirect fluorescent antibody staining of wild-type (H37Rv), lprG
mutant (DlprG), and DlprG complemented with lprG-Rv1410c (::lprG) with anti-LAM antibodies. Bacilli cultured in shaking broth cultures were washed,
fixed in 4% paraformaldehyde, and then suspended in 5% bovine serum albumin for 1 h. Bacilli were incubated with primary antibodies (1u Ab) rabbit
anti-LAM pAb (a-LAM) and mouse anti-LAM mAb (CS-35), washed, and then incubated with secondary antibodies (2u Ab), goat anti-rabbit IgG Fab2-
Alexa fluor and goat anti-mouse IgG IgG-Dylight, respectively. Bacilli were mounted with DAPI-containing medium and visualized using a fluorescent
microscope. (A) Confocal images showing positive staining bacteria with a-LAM (arrow). (B and C) Bar graphs show average percent of bacteria staining
positive with a-LAM (B) and CS-35 (C) 6SD of three independent experiments. DlprG and ::lprG were compared to H37Rv. **P,0.01; ***P,0.001.
doi:10.1371/journal.ppat.1004376.g003
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surface LAM based on anti-LAM staining. Alternatively, LprG
may be essential for minor modification of the LAM side-chains,
which would impact normal surface chemistry and LAM
immunostaining. We also showed that the lprG mutant has a
smaller colony size on agar. The exact role of surface LAM in
colony size remains to be determined but the phenotype may be
due to the altered surface property of the lprG mutant.
Alternatively, LprG could have a secondary function that is
unrelated to orienting LAM.
Prior studies using purified mannose-capped LAM from M.
tuberculosis have identified it as a key virulence determinant for
cell entry and inhibition of P-L fusion, which presumably leads to
intracellular survival and persistence [8]. However, until now,
confirmation of these virulence properties in LAM mutants had
not been possible due to the essentiality of genes in the LAM
biosynthetic pathway [8,9]. Here we characterized the functional
consequences of surface LAM deficiency in the lprG mutant. We
showed that the lprG mutant is in fact less efficient at macrophage
entry and inhibition of P-L fusion, and is attenuated for replication
in macrophages. These findings are consistent with the attenuated
phenotype of the lprG mutant reported in mice [22,23]. Our study
extends the observations made in vivo by providing a more
detailed characterization of the mutant in mice after aerosol
infection, which more closely approximates natural infection in
humans. We showed that while the lprG mutant is able to survive
and partially replicate in the mouse lung during the acute phase of
infection when innate immunity is in operation, the mutant is
killed in the lung with the onset of adaptive immunity [29]. The
attenuation during the acute phase may be ascribed to the
deficiency of the mutant to enter host cells. We also showed that
the attenuation of the lprG mutant in resting and IFN-c-activated
wild-type macrophages is not rescued in p47phox2/2 or
iNOS2/2 macrophages, indicating that the lprG mutant is not
hypersensitive to reactive oxygen and nitrogen species, respective-
ly. This finding is inconsistent with the observation by Chan and
colleagues that LAM has the property of scavenging oxygen free
radicals [31]. Perhaps the orientation of LAM on the surface is not
essential for the scavenging property. However, confirmation of
our findings in knockout mice is essential because enhanced
replication of H37Rv or ::lprG in either p47phox2/2 or
iNOS2/2 macrophages was not observed. The lprG mutant
also has a cell envelope defect based on increased susceptibility to
Figure 4. The lprG mutant is impaired for macrophages entry. (A) Resting BMMW from C57BL/6 mice were infected with wild-type (H37Rv),
lprG mutant (DlprG), and DlprG complemented with lprG-Rv1410c (::lprG) at MOI of 1:10 (Input). At 4 h post-infection cells were washed and
intracellular bacteria (Output) were enumerated on agar. Bar graph shows average CFU counts 6SEM of three independent experiments performed
in triplicate wells. (B–D) RAW 264.7 macrophages treated with and without 4 mg/ml mannan or 0.5 mg/ml anti-MMR pAb were infected with FITC-
labeled bacteria at MOI of 1:100 for 2 h. Cells were washed, mounted and visualized using a fluorescent microscope. Graphs show percentage of
infected cells with no treatment (B), treated with mannan (C) and treated with anti-MMR pAb (D). Bars show average percentage 6SEM of two
independent experiments performed in triplicates. DlprG and ::lprG were compared to H37Rv. *P,0.05.
doi:10.1371/journal.ppat.1004376.g004
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SDS which suggests the in vivo attenuation of the lprG mutant
may be, in part, due to permeability to immune effectors such as
antimicrobial peptides [20]. Other potential mechanisms of
attenuation not investigated in this study include loss of LAM-
dependent inhibition of protein kinase C activity [31], expansion
of regulatory T cells [32], and suppression of a dendritic cell pro-
inflammatory program [33]. Furthermore, although our results
strongly indicate LAM orientation is the major factor that
modulates the surface chemical property of the lprG mutant, we
are unable to rule out the possibility that interaction of LprG with
phosphatidylinositol mannosides, lipomannan, and/or other lipo-
glycan contributes to the phenotypes observed in the lprG mutant.
The bacteria used for cell-imprinting and surface staining
experiments in this study were grown under perturbing conditions
(in the presence of 0.05% Tween-80 and mechanical agitation).
Using cryo-electron microscopy (EM) and immuno gold-EM, Sani
Figure 5. The lprG mutant is impaired for inhibition of Phagosome-Lysosome fusion. RAW 264.7 cells were treated with 50 nM
LysoTracker-Red with and without 4 mg/ml mannan or 0.5 mg/ml anti-MMR pAb. Cells were incubated for 30 min, and then infected with FITC-
labeled wild-type (H37Rv), lprG mutant (DlprG), and DlprG complemented with lprG-Rv1410c (::lprG) at MOI of 1:100 for 2 h. Cells were washed,
mounted, and visualized using a fluorescent microscope. (A) Confocal images showing bacteria in green, lysosomes in red, and the nucleus in blue.
Scale bars, 5 mm. 2.56magnification is shown on the right. (B–D) Graphs show average percentage of bacilli co-localized with lysosomes in cells with
no treatment (B), treated with mannan (C) and treated with anti-MMR pAb (D). Bars show average percentage 6SEM of two to three independent
experiments performed in triplicates. DlprG and ::lprG were compared to H37Rv. *P,0.05.
doi:10.1371/journal.ppat.1004376.g005
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and colleagues showed that under non-perturbing conditions
mycobacteria express a thick capsule that labels with anti-LAM
but under perturbing conditions mycobacteria shed their capsule
[6]. Although anti-LAM surface labeling was reduced under
perturbing conditions, as much as 80% of mycobacteria in some
experiments stained positive with anti-lipoglycan antiserum. Thus,
although we were not able to compare surface LAM properties of
the lprG mutant to wild-type bacteria under non-perturbing
conditions due to bacterial clumping, our surface LAM staining
results in wild-type bacteria are consistent with the above study;
perturbing conditions still allowed us to detect a measurable
difference in the lprG mutant. Furthermore, although the
biological significance of perturbing and non-perturbing condi-
tions in the context of lung environments is unknown, the fact that
cell surface alteration has been reported under non-perturbing
conditions [21,30] suggests the lprG mutant has a surface defect that
manifests itself under both perturbing and non-perturbing conditions.
The findings of this study have translational implications for
tuberculosis control and eradication. First, the elimination of the
lprG mutant from mouse lung during the adaptive phase of
infection makes LprG and P55 attractive drug targets. There has
been a growing interest in repurposing of efflux pump inhibitors
currently approved for other disorders as a way of increasing the
susceptibility of M. tuberculosis to anti-tuberculosis drugs and thus
shortening the duration of therapy [34,35]. Using the cell-
imprinting assay described in this study, we may be able to
identify efflux pump inhibitors that target P55 and chemically
achieve an LprG null phenotype. The repurposing of efflux pump
inhibitors with activity against P55 may be particularly useful for
treatment of strains that are resistant to existing drugs. Secondly,
the elimination of the lprG mutant from the mouse lung with the
onset of adaptive immunity together with the loss of immuno-
modulatory effects of surface LAM in the lprG mutant raise the
possibility that this mutant elicits an adaptive immune response
that is capable of achieving sterilizing immunity. Further studies
are underway to determine whether elimination of the lprG
mutant is due to a more able adaptive immune response or due to
a less resistant mutant. If the former is true, the lprG mutant may
have utility as a vaccine candidate for prevention of M.
tuberculosis infection.
Materials and Methods
Ethics statement
All animal experiments were done in accordance with
procedures approved by the NYU School of Medicine Institutional
Animal Care and Use Committee and in strict accordance with
the recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health under the
Assurance of Compliance Number A3435-01.
Bacteriologic media
M. tuberculosis was grown in Middlebrook 7H9 broth (DifCo)
supplemented with 0.2% glycerol, 10% OADC (DifCo), and
Figure 6. The lprG mutant cannot persist in mouse lung. (A) C57BL/6 mice were infected wild-type (H37Rv), lprG mutant (DlprG), and DlprG
complemented with lprG-Rv1410c (::lprG) through the aerosol route and bacterial load in the lung was measured at the indicated time points. Data
points show average CFU count 6SD of 4 mice per time point. (B) Representative lungs on day 70 post-infection. Data is representative of two
independent experiments. DlprG and ::lprG were compared to H37Rv. **P,0.01; ***P,0.005.
doi:10.1371/journal.ppat.1004376.g006
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0.05% Tween-80. For lipid and lipoglycan analysis bacteria were
grown in Glycerol-Alanine-Salts (GAS) medium with shaking.
Middlebrook 7H9 agar with 0.2% glycerol, 10% ADC was used
for enumeration of bacterial colonies.
Strain construction
The lprG deletion mutant (DlprG) was constructed in the
H37Rv strain with conditionally replicating mycobacteriophages
as previously described [36]. Primer sequences used in this study
are shown in Table S5. To complement the DlprG, two PCR-
amplified fragments of 1571 bp and 1060 bp, encoding the lprG-
Rv1410c operon and the native promoter, were directionally
cloned into the integrative plasmid pMV306. The DlprG and the
DlprG complemented with DlprG-Rv1410c (::lprG) were con-
firmed by real-time PCR using genomic DNA and cDNA,
respectively (Figure S1). Construction of DlspA and DwhiB3 was
previously described [37,38].
Preparation and analysis of lipids and lipoglycans
Capsular materials were extracted with glass beads as described
previously [24]. Culture filtrates (0.22 mm filters) containing the
secreted and shed material were similarly prepared. Capsular and
culture filtrate materials were concentrated and dialyzed exten-
sively against water prior to analyses. Lipoglycans were prepared
from bacterial cells and analyzed by SDS-PAGE on 10–20%
gradient Tricine SDS-polyacrylamide gels (Invitrogen) as de-
scribed previously [39]. Lipids were extracted from bacterial cells,
capsular materials and culture filtrates as previously described [40]
and analyzed by TLC on aluminum-backed silica gel 60-precoated
plates F254 (E. Merck) in a variety of solvent systems [41]. The
phosphatidylinositol mannoside content of the cells was also
examined by submitting total lipids to MALDI-TOF MS analysis
[39]. Mycolic acid methyl esters from delipidated cells were
prepared as described earlier [40] and analyzed by TLC using n-
hexane/ethyl acetate (95:5) as the eluent and LC-MS [42]. The
glycosyl composition of whole delipidated cells, culture filtrates
and capsular materials were determined by acid hydrolysis with 2
M trifluoroacetic acid followed by analysis of the alditol acetate
sugar derivatives by GC-MS as previously described [43].
Capsular a-glucan content was measured with a spot immunoblot
assay. Blots were blocked and incubated with goat anti-
phosphatidylinositol-glycans polyclonal IgG antibody (Santa Cruz
Biotechnology), at a dilution of 1/200, and donkey anti-goat IgG-
HRP secondary antibody, at a dilution of 1/200. The blot was
washed with TBS-0.5% Tween-20, and then treated with 30%
3,39-diaminobenzidine tetrahydrochloride solution plus 0.0005%
H2O2 until dots became visible. Dead-dextran (Sigma) and
glycogen (Santa Cruz Biotechnology) were used as positive
controls.
LAM immunoblot
Whole cell lysates were prepared as previously described [27].
Soluble protein concentration was measured (BCA Protein Assay;
Pierce Biotechnology). Lysates were normalized to protein content
and separated on a 15% SDS/PAGE gel and transferred to a
PVDF membrane. The membrane was blocked with 3% BSA in
TBS-0.5% Tween-20, and then incubated with rabbit anti-LAM
polyclonal IgG (a-LAM; BEI Resources), at a dilution of 1/200,
overnight at 4uC. The membrane was washed with TBS-0.5%
Tween-20 and incubated with goat anti-rabbit IgG-HRP (Santa
Cruz Biotechnology), at a dilution of 1/400, for 90 min at 24uC.
The membranes and images were developed as described above.
Surface LAM staining
Mid-log shaking cultures were centrifuged at 800 rpm for 8 min
to remove clumps. Bacilli were washed with PBS and fixed in 4%
paraformaldehyde, and then resuspended in PBS and incubated in
5% bovine serum albumin for 1 h. Bacilli were sedimented and
suspended in 3% bovine serum albumin with a-LAM, at a dilution
of 1/100, or mouse anti-LAM monoclonal IgG (CS-35; BEI
Resources), at a dilution of 1/150, and incubated overnight at
4uC. Bacilli were washed with PBS-0.02% Tween-20 and
resuspended in PBS with goat anti-rabbit IgG Fab2-Alexa fluor
(Cell Signalling), at a dilution of 1/200, and goat anti-mouse IgG
IgG-Dylight (Cell Signalling), at a dilution of 1/100, respectively,
for 2 h at 24uC. Bacilli were washed, mounted with VECTA-
SHIELD HardSet (Vector Laboratory), and visualized using a
fluorescent microscope. The reader was blinded to the identity of
each sample and graded each bacillus as positive (dim and bright)
or negative staining.
Cell-imprinting
Mid-log shaking cultures were sedimented, washed in PBS, and
then fixed in 4% paraformaldehyde. Cell-imprinting was per-
formed as previously described [25,26]. Briefly, one drop of
bacteria in PBS at an OD580 of 2 was placed on a polystyrene slide
(Evergreen) and incubated overnight at 4uC. The excess liquid on
the slide was removed by spinning the slide at 2000 rpm for
30 sec. The slide was air-dried, heated at 60uC for 2 h, rinsed with
deionized water, air-dried, and used as a template for imprinting.
To create a cell imprint, PDMS curing mixture (monomer to
cross-linker ratio 10:1) (GE Silicone) with cyclohexane (2:1
volume) and 0.5% poly (ethylene glycol) methyl ether methacrylate
(Sigma Aldrich) was spin-coated onto a microscope slide for 30 sec
at 1500 rpm. The PDMS was pre-cured at 80uC for 12 min. The
template stamp was pressed into PDMS and incubated at 37uC for
8 h, followed by 60uC for 1 h. The template was peeled off and
the imprinted polymer film was sonicated in distilled water for
5 min. The cell-imprinted substrates were then inspected with a
scanning probe microscope (XE-70, Park Systems) under non-
contact AFM (tapping) mode, using etched silicon cantilevers
(resonance frequency ,300 kHz, tip radius ,10 nm) with
medium-low tip oscillation damping ,15% and a scan rate of
0.2 Hz. Geometric information of the imprints was extracted using
XEI (Park Systems).
For cell capture studies, bacterial suspensions in PBS at an
ODA580 of 0.01 were incubated in PBS alone and with a-LAM at
a dilution of 1/20, with CS-35 at a dilution of 1/10, rabbit IgG
isotype control at a dilution of 1/10, and with mouse anti-Ag85
complex monoclonal IgM (CS-90; BEI Resources) at a dilution of
1/10. Bacilli were fluorescently labeled with propidium iodide
(Invitrogen) and 25 ml was passed at 5 ml/min through a
microfluidic device containing the imprints of H37Rv, DlprG,
and ::lprG. After the infusion process, cells captured on each
Figure 7. The lprG mutant is attenuated in mouse macrophages. Resting and IFN-c-activated BMMW from C57BL/6 (A, B, E, and F), p-
47phox2/2 (C and D), and iNOS2/2 (G, H) mice were infected with wild-type (H37Rv), lprG mutant (DlprG), and DlprG complemented with lprG-
Rv1410c (::lprG) at MOI of 1:10 (A–D) and 1:40 (E–H). Intracellular bacteria were enumerated on Middlebrook 7H9 agar on the indicated days. Data
points represent average CFU 6SD of triplicate wells. Data is representative of two to three independent experiments.
doi:10.1371/journal.ppat.1004376.g007
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imprint were imaged using an iXon+ electron-multiplying CCD
camera (Andor Technology) and Andor Solis microscopy imaging
software. A custom program written on LabVIEW (National
Instruments) was used to control the stage to allow stepwise
scanning of 8 adjacent view fields (280 mm6280 mm). The images
were analyzed using ImageJ (National Institutes of Health) and the
average number of cells captured per 8 view fields was measured.
The operator was not blinded to where the scanning was initiated
or scoring of images, however, blinded scoring of H37Rv, DlprG,
and ::lprG sample images from Figure 2C by a blinded reader
showed both quantitative and statistical agreement with the
unblinded results (interclass correlation coefficient of 0.9).
SEM
Single cell suspensions of bacilli were fixed overnight at 24uC on
poly-lysine coated glass slides in 0.1 M sodium cacodylate pH 7.3
containing 4% formaldehyde and 2% glutaraldehyde, followed by
1% aqueous osmium tetroxide for 1 h, and then dehydrated in an
increasing ethanol concentrations series (50% to 100%), and
finally critical-point-dried in liquid carbon dioxide using Tousimis
Autosamdri 814. Immediately after the process, the samples were
coated with a thin layer (7.5 nm thick) Au/Pt mixture using
Denton DeskII sputtering system, and inspected using field
emission SEM (Sigma HD, Zeiss) under high vacuum mode with
working distance of 5 mm. Cellular measurements were per-
formed using Freehand software (Adobe).
Phagosome-Lysosome co-localization
RAW 264.7 cells were cultivated in Dulbecco’s Modified Eagle
Medium (Corning) supplemented with 10% fetal bovine serum,
1% L-glutamine, and 1% non-essential amino acids and plated on
Lab-Tek chamber slides. Lysosomal and bacterial staining were
performed as previously described [44,45]. Briefly, RAW cells
were treated with 50 nM LysoTracker-Red DND-99 (Life
Technology) with and without MMR blocking with 4 mg/ml
mannan (Sigma) or 0.5 mg/ml anti-MMR/CD206 pAb (R&D
Systems). Cells were incubated for 30 min, and then infected with
FITC-labeled bacteria at MOI of 1:100 for 2 h. Cells were washed
with PBS, fixed in 4% paraformaldehyde, mounted with
VECTASHIELD HardSet, and visualized using a fluorescent
microscope. The reader was blinded to the identity of each
sample.
Macrophage infections
Bone marrow-derived macrophages (BMMW) were isolated
from mice as previously described [38] and plated at a density of
56105 cells per well. Bacterial cultures were sedimented, washed
with PBS, and resuspended in BMMW media. Monolayers were
infected at MOI of 1:10 or 1:40 and activated with recombinant
IFN-c 20 ng/ml. At 4 h post-infection, monolayers were washed
with PBS and replaced in fresh BMMW media. At the indicated
times, monolayers were lysed in 1 ml of PBS with 0.5% triton X-
100 and bacterial counts were enumerated.
Mouse infections
C57BL/6 mice were purchased from The Jackson Laboratory
and housed under specific pathogen-free conditions. Mice were
used in compliance with NYU institutional policies. Aerosol
infections were performed in an inhalation exposure device (Glas-
Col) as previously described [38]. On designated dates, mice were
sacrificed and the lungs were homogenized in 2 ml of PBS with
0.5% tween 80 and the bacterial CFU counts were enumerated on
Middlebrook 7H11.
Statistical analysis
The student t-test was used to determine significant differences
between groups.
Supporting Information
Figure S1 Construction of the lprG mutant. (A) The
genomic map of lprG-Rv1410c operon in M. tuberculosis H37Rv.
(B) The allelic exchange substrate used to construct the lprG
mutant (DlprG). Hyg, hygromycin. (C) The genomic map of lprG-
Rv1410c operon in DlprG. The black box represents region
deleted from lprG. (D) The lprG-Rv1410c genomic fragment used
to complement DlprG. (E) Real-time PCR amplification plot
showing amplification of lprG from genomic DNA. (F) Reverse-
transcriptase real-time PCR amplification plot showing amplifica-
tion of Rv1410c from cDNA.
(TIF)
Figure S2 The lprG mutant has normal growth kinetics
in broth. Mid-log shaking broth cultures of wild-type (H37Rv),
lprG mutant (DlprG), and DlprG complemented with lprG-
Rv1410c (::lprG) were diluted to ODA580 of 0.05 in Middlebrook
7H9 broth with Tween-80. (A) The optical density of shaking cultures
was measured daily. (B) Images of colonies grown on Middlebrook
7H9 agar for 3 wk. White bars mark the borders of colonies.
(TIF)
Figure S3 The lprG mutant has normal cellular dimen-
sions. SEM micrographs of H37Rv (A and B) and DlprG (C and
D). Wild-type (H37Rv) and lprG mutant (DlprG) bacilli grown in
Middlebrook 7H9 broth were fixed with 4% formaldehyde, 2%
glutaraldehyde, followed by 1% aqueous osmium tetroxide, and
then dehydrated and coated with a thin layer of Au/Pt mixture
before inspection using SEM. AFM images of imprints of H37Rv
(E) and DlprG (F) in PDMS polymer. Pre-fixed bacilli were dried
on polystyrene glass slides and used as template stamps to press
into pre-cured PDMS polymer. The polymer was cured, the stamp
was peeled off, and then the geometrical shape of the imprints was
extracted using AFM. (G) Dimensions of H37Rv and DlprG
obtained with SEM and AFM. Each value is an average of nine
bacilli 6SD.
(TIF)
Figure S4 Phosphatidylinositol mannoside and treha-
lose dimycolate content of the lprG mutant. Thin-layer
chromatograms of total lipids extracted from wild-type (H37Rv;
1), lprG mutant (DlprG; 2), and DlprG complemented with lprG-
Rv1410c (::lprG; 3). The same amounts of total lipids were loaded
for each strain. TLC plates were run in the solvent system CHCl3/
CH3OH/H2O (20:4:0.5, by vol.) and revealed with a-naphthol.
TDM, trehalose dimycolates; SL, sulfolipid; CL, cardiolipin;
PIM2, phosphatidylinositol dimannosides; TDM Std, TDM
standard.
(TIF)
Figure S5 Cell-imprinting assay using bacteria pre-
treated with an isotype control. (A) Samples of wild-type
(H37Rv), lprG mutant (DlprG), and DlprG complemented with
lprG-Rv1410c (::lprG) suspended in PBS at an ODA580 of 0.01
were pretreated with rabbit IgG isotype control at a dilution of 1/
10 and then fluorescently labeled with propidium iodide and 25 ml
was flowed at 5 ml/min through a microfluidic device containing
the imprints of H37Rv, DlprG, and ::lprG. The average number
of captured bacilli per eight view fields was measured using a
fluorescent microscope. Data is representative of three independent
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experiments. Capture on imprints of DlprG and ::lprG was
compared to H37Rv. *P,0.05; **P,0.01.
(TIF)
Table S1 Number of H37Rv, DlprG, and ::lprG captured
on cell-imprints of H37Rv, DlprG, and ::lprG.
(DOC)
Table S2 Number of H37Rv, DlprG, and ::lprG captured
on cell-imprints of H37Rv, DlprG, and ::lprG after pre-
incubation of samples with anti-LAM polyclonal anti-
body a-LAM.
(DOC)
Table S3 Number of H37Rv, DlprG, and ::lprG captured
on cell-imprints of H37Rv, DlprG, and ::lprG after pre-
incubation of samples with anti-Ag85b complex mono-
clonal antibody CS-90.
(DOC)
Table S4 Number of H37Rv, DlprG, and ::lprG captured
on cell-imprints of H37Rv, DlprG, and ::lprG after pre-
incubation of samples with anti-LAM isotype control
antibody.
(DOC)
Table S5 Primers used in this study.
(PDF)
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